Microsporidiosis After Solid Organ Transplantation: A Multi‐Species Case Series

BACKGROUND: Microsporidiosis is an uncommon opportunistic infection in solid organ transplant (SOT) recipients. Case-level data on multi-species disease and management remain limited. METHODS: We retrospectively reviewed SOT recipients with microsporidiosis at Mayo Clinic from January 2000 through February 2026. Cases were identified by text search and institutional polymerase chain reaction (PCR) records. Clinical, microbiologic, treatment, immunosuppression, and outcome data were abstracted. RESULTS: Ten recipients were identified: six kidney, two kidney-pancreas, and two heart recipients. Eight had enteritis and two had disseminated disease. Enterocytozoon bieneusi caused seven infections; the remaining cases were Encephalitozoon sp. enteritis, disseminated E. cuniculi, and disseminated Anncaliia algerae. All enteritis cases experienced diarrhea; seven experienced weight loss, five developed acute kidney injury, and five required hospitalization. The most common treatment administered was nitazoxanide (n = 6). Among these three achieved clinical remission, one improved without documented remission, and two had transient or partial improvement followed by recurrent diarrhea. Among four patients whose antimetabolite was held, reduced, or replaced at or before treatment, all improved clinically. In the two initially treated without antimetabolite modification, responses were transient or incomplete. Both Encephalitozoon infections achieved clinical remission with albendazole. Disseminated A. algerae was fatal. CONCLUSIONS: Microsporidiosis after SOT demonstrated a species-associated clinical spectrum: E. bieneusi was confined to enteritis, whereas non-E. bieneusi species caused both enteric and disseminated disease. In E. bieneusi enteritis, nitazoxanide improved symptoms, but responses were incomplete when antimetabolite therapy was continued. Encephalitozoon infections responded to albendazole, whereas disseminated A. algerae was refractory and fatal.

Authors

Institutions

Publication Details

Journal
Transplant Infectious Disease
Published
2026-10-26
DOI
https://doi.org/10.1111/tid.70343
Primary Topic
Parasitic Infections and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microsporidiosis After Solid Organ Transplantation: A Multi‐Species Case Series

Bobbi S. Pritt, Raymund Rabe Razonable, Zahra N. Sohani, Omar Abu Saleh et al.
Transplant Infectious Disease
Parasitic Infections and Diagnostics
article

Microsporidiosis After Solid Organ Transplantation: A Multi‐Species Case Series

Bobbi S. Pritt, Raymund Rabe Razonable, Zahra N. Sohani, Omar Abu Saleh, Jack McHugh
article en

Abstract

BACKGROUND: Microsporidiosis is an uncommon opportunistic infection in solid organ transplant (SOT) recipients. Case-level data on multi-species disease and management remain limited. METHODS: We retrospectively reviewed SOT recipients with microsporidiosis at Mayo Clinic from January 2000 through February 2026. Cases were identified by text search and institutional polymerase chain reaction (PCR) records. Clinical, microbiologic, treatment, immunosuppression, and outcome data were abstracted. RESULTS: Ten recipients were identified: six kidney, two kidney-pancreas, and two heart recipients. Eight had enteritis and two had disseminated disease. Enterocytozoon bieneusi caused seven infections; the remaining cases were Encephalitozoon sp. enteritis, disseminated E. cuniculi, and disseminated Anncaliia algerae. All enteritis cases experienced diarrhea; seven experienced weight loss, five developed acute kidney injury, and five required hospitalization. The most common treatment administered was nitazoxanide (n = 6). Among these three achieved clinical remission, one improved without documented remission, and two had transient or partial improvement followed by recurrent diarrhea. Among four patients whose antimetabolite was held, reduced, or replaced at or before treatment, all improved clinically. In the two initially treated without antimetabolite modification, responses were transient or incomplete. Both Encephalitozoon infections achieved clinical remission with albendazole. Disseminated A. algerae was fatal. CONCLUSIONS: Microsporidiosis after SOT demonstrated a species-associated clinical spectrum: E. bieneusi was confined to enteritis, whereas non-E. bieneusi species caused both enteric and disseminated disease. In E. bieneusi enteritis, nitazoxanide improved symptoms, but responses were incomplete when antimetabolite therapy was continued. Encephalitozoon infections responded to albendazole, whereas disseminated A. algerae was refractory and fatal.

Transplant Infectious Disease
Mayo Clinic (US)
Openalex Percentile: Top 11%
Parasitic Infections and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon